1426 Combination with BCA101 improves the efficacy of KRAS-G12C inhibitor and overcomes G12C inhibitor-induced resistance in lung and colon cancer cell lines

• Rachel Salazar,
• Reshmi Nair,
• Pradip Nair,
• Veena Somasundaram,
• Shiv Ram Krishn

Affiliations

Rachel Salazar

Aff168 grid.467308.e0000 0004 0412 6436EMD Serono Billerica MA USA

Reshmi Nair

1Biofusion Therapeutics Limited, Bangalore, India

Pradip Nair

1Biofusion Therapeutics Limited, Bangalore, India

Veena Somasundaram

1Syngene International Limited, Bengaluru, Karnataka, India

Shiv Ram Krishn

1Syngene International Limited, Bengaluru, Karnataka, India